Pergolide in the treatment of Parkinson's diseaseMEAR, J.-Y; BARROCHE, G; DE SMET, Y et al.Neurology. 1984, Vol 34, Num 7, pp 983-986, issn 0028-3878Article

In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-dopaPONZIO, F; CIMINO, M; ACHILLI, G et al.Life sciences (1973). 1984, Vol 34, Num 22, pp 2107-2116, issn 0024-3205Article

Determination of the enantiomeric purity of levodopa, methyldopa, carbidopa and tryptophan by use of chiral mobile phase high-performance liquid chromatographyGELBER, L. R; NEUMEYER, J. L.Journal of chromatography. 1983, Vol 257, Num 2, pp 317-326, issn 0021-9673Article

Simple and rapid micromethod for the determination of levodopa and 3-O-methyldopa in human plasma by high-performance liquid chromatography with coulometric detectionBARUZZI, A; CONTIN, M; ALBANI, F et al.Journal of chromatography. 1986, Vol 375, Num 1, pp 165-169, issn 0021-9673Article

High-performance liquid chromatographic determination of amantadine in urine after micelle-mediated pre-column derivatization with 1-fluoro-2,4-dinitrobenzeneVAN DER HORST, F. A. L; TEEUWSEN, J; HOLTHUIS, J. J. M et al.Journal of pharmaceutical and biomedical analysis. 1990, Vol 8, Num 8-12, pp 799-804, issn 0731-7085, 6 p.Conference Paper

2.128.705 (B) (7207885). - 7 MARS 1972. PROCEDE DE PREPARATION DE 3-(3,4-DIHYDROXYPHENYL)-L-ALANINE ET DE SES INTERMEDIAIRES ET NOUVEAUX PRODUITS AINSI OBTENUSsdPatent

NEW COMPOUNDS: RESOLUTION OF D,L-ALPHA -BENZAMIDO-4-HYDROXY-3-METHOXYDIHYDROCINNAMIC-ACID, A PRECURSOR OF L-3,4-DIHYDROXYPHENYLALANINE = NOUVEAUX COMPOSES: RESOLUTION DE L'ACIDE D,L-ALPHA -BENZAMIDO-HYDROXY-4 METHOXY-3 DIHYDROCINNAMIQUE, UN PRECURSEUR DE LA L-DIHYDROXY-3,4 PHENYLALANINESCHWAN TJ; BURCH HA.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 9; PP. 1506-1507; BIBL. 4REF.Serial Issue

2.132.287 (B) (7211354). - 30 MARS 1972. PROCEDE POUR L'OBTENTION DE L (-)-3,4-DIHYDROXYPHENYLALANINEsdPatent

EFFECT OF L-DOPA IN SCHIZOPHRENIAINANAGA K; INOUE K; TACHIBANA H et al.1972; FOLIA PSYCHIATR. NEUROL. JAP.; JAP.; DA. 1972; VOL. 26; NO 2; PP. 145-157; BIBL. 13 REF.Article

Carbidopa dosage modifies L-DOPA induced side effects and blood levels of L-DOPA and other aminoacids in advanced parkinsonismPAREJA, F. B; MARTINEZ-MARTIN, P; MURADAS, V et al.Acta neurologica scandinavica. 1985, Vol 72, Num 5, pp 506-511, issn 0001-6314Article

Antiparkinsoniens = Antiparkinson drugsRONDOT, P; DE RECONDO, J; MONTASTRUC, J. L et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 40, pp 2817-2846, issn 0037-1777Article

Comparison of the stimulatory effects of eight antiparkinsonian drugsGOLDSCHMIDT, P. L; SAVARY, L; SIMON, P et al.Progress in neuro-psychopharmacology & biological psychiatry. 1984, Vol 8, Num 2, pp 257-261, issn 0278-5846Article

DIPHENYLHYDANTOIN. BLOCKING OF LEVODOPA EFFECTS = DIPHENYLHYDANTOINE. BLOCAGE DES EFFETS DE LA L-DOPAMENDEZ JS; COTZIAS GC; MENA I et al.1975; ARCH. NEUROL.; U.S.A.; DA. 1975; VOL. 32; NO 1; PP. 44-46; BIBL. 30REF.Article

ANTIPARKINSONISM DRUGSVERNIER VG.1974; ANNU. REP. MEDICIN. CHEM.; U.S.A.; DA. 1974; VOL. 9; PP. 19-26; BIBL. 2P.Article

DOPAMINE ET ANTAGONISME PARKINSON-CHOREEBULANDRA R; SERBANESCO A.1973; REV. NEUROL.; FR.; DA. 1973; VOL. 127; NO 2; PP. 315Serial Issue

2.113.902 (B) (7140335). - 10NOVEMBRE1971. DERIVES DE PHENYLALANINEsdPatent

MORPHOLOGIC AND BIOCHEMICAL CHANGES IN THE GUT AFTER CHRONIC TREATMENT WITH L-DOPA = MODIFICATIONS MORPHOLOGIQUES ET BIOCHIMIQUES DANS L'INTESTIN, APRES LE TRAITEMENT CHRONIQUE PAR LA LEVODOPARIVERA CALIMLIN L; BOSMANN HB; PENNEY DP et al.1973; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1973; VOL. 184; NO 2; PP. 440-448; BIBL. 1 P.Serial Issue

THE PHOTODEGRADATION OF L-DOPA AND RELATED COMPOUNDS = LA PHOTODEGRADATION DE LA L-DOPA ET DES COMPOSES APPARENTESDEARDEN JC; ELRICK JG.1972; J. PHARM. PHARMACOL., SUPPL.; G.B.; DA. 1972; VOL. 24; SUPPL.; PP. 140-141; BIBL. 2 REF.Serial Issue

2.118.100 (B) (7145099). - 15DECEMBRE 1971. DERIVES DE L'ACRIDANE ET MEDICAMENTS QUI EN CONTIENNENTsdPatent

2.133.822 (B) (7213458). - 17AVRIL 1972. NOUVEAUX DERIVES DE L'ACIDE PICOLIQUE ET PROCEDE POUR LEUR PREPARATIONsdPatent

NEW PATHWAY FOR METABOLISM OF DOPA = NOUVELLE VOIE DE METABOLISME DE LA DOPAO'LEARY MH; BAUGHN RL.1975; NATURE; G.B.; DA. 1975; VOL. 253; NO 5486; PP. 52-53; BIBL. 14REF.Article

PRECLINICAL TOXICOLOGICAL STUDIES OF CARBIDOPA AND COMBINATIONS OF CARBIDOPA AND LEVODOPA = ETUDES TOXICOLOGIQUES PRECLINIQUES DU CARBIDOPA ET DE L'ASSOCIATION DU CARBIDOPA ET DU LEVODOPAZWICKEY RE; PECK HM; BAGDON WJ et al.1974; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 29; NO 2; PP. 181-195; BIBL. 1P. 1/2Article

EFFECT OF L-DOPA ON THE FINE STRUCTURE OF DOG LIVERMOTTONEN M; NEVALAINEN T; NIEMINEN L et al.1972; RES. EXPER. MED.; GERM.; DA. 1972; VOL. 159; NO 2; PP. 108-113; ABS. ALLEM.; BIBL. 9 REF.Serial Issue

DETERMINATION DU TRIHEXYPHENIDYLE PAR EXTRACTION-PHOTOMETRIE ET CONDITIONS DE SON EXTRACTION A PARTIR DES SOLUTIONS AQUEUSES PAR DES SOLVANTS ORGANIQUES1972; FARM. ZH., U.R.S.R.; S.S.S.R.; DA. 1972; VOL. 27; NO 3; PP. 82-84Serial Issue

THERAPEUTIC REVERSAL WITH BENZTROPINE IN SCHIZOPHRENICS. PRACTICAL AND THEORETICAL SIGNIFICANCE = INVERSION THERAPEUTIQUE AVEC LA BENZTROPINE CHEZ LES SCHIZOPHRENES. SIGNIFICATION PRATIQUE ET THEORIQUEMAN MOHAN SINGH; KAY SR.1975; J. NERV. MENTAL DIS.; U.S.A.; DA. 1975; VOL. 160; NO 4; PP. 258-266; BIBL. 17REFArticle